✦ LIBER ✦
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
✍ Scribed by Donna L. Forrest; Shannon Trainor; Ryan R. Brinkman; Michael J. Barnett; Donna E. Hogge; Thomas J. Nevill; John D. Shepherd; Stephen H. Nantel; Cynthia L. Toze; Heather J. Sutherland; Kevin W. Song; Julye C. Lavoie; Maryse M. Power; Yasser Abou-Mourad; Clayton A. Smith
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 162 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.